Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-051222
Filing Date
2005-03-15
Accepted
2005-03-15 17:11:24
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 689523
2 BOARD OF DIRECTOR'S COMPENSATION STRUCTURE dex1049.htm EX-10.49 14534
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1768
4 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 11392
5 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 11442
6 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3685
7 CERTIFICATIONS BY THE CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3698
8 GRAPHIC g11590g24e57.jpg GRAPHIC 16853
  Complete submission text file 0001193125-05-051222.txt   755483
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23265 | Film No.: 05682488
SIC: 2834 Pharmaceutical Preparations